PINK1-parkin-mediated neuronal mitophagy deficiency in prion disease

Abstract

A persistent accumulation of damaged mitochondria is part of prion disease pathogenesis. Normally, damaged mitochondria are cleared via a major pathway that involves the E3 ubiquitin ligase parkin and PTEN-induced kinase 1 (PINK1) that together initiate mitophagy, recognize and eliminate damaged mitochondria. However, the precise mechanisms underlying mitophagy in prion disease remain largely unknown. Using prion disease cell models, we observed PINK1-parkin-mediated mitophagy deficiency in which parkin depletion aggravated blocked mitochondrial colocalization with LC3-II-labeled autophagosomes, and significantly increased mitochondrial protein levels, which led to inhibited mitophagy. Parkin overexpression directly induced LC3-II colocalization with mitochondria and alleviated defective mitophagy. Moreover, parkin-mediated mitophagy was dependent on PINK1, since PINK1 depletion blocked mitochondrial Parkin recruitment and reduced optineurin and LC3-II proteins levels, thus inhibiting mitophagy. PINK1 overexpression induced parkin recruitment to the mitochondria, which then stimulated mitophagy. In addition, overexpressed parkin and PINK1 also protected neurons from apoptosis. Furthermore, we found that supplementation with two mitophagy-inducing agents, nicotinamide mononucleotide (NMN) and urolithin A (UA), significantly stimulated PINK1-parkin-mediated mitophagy. However, compared with NMN, UA could not alleviate prion-induced mitochondrial fragmentation and dysfunction, and neuronal apoptosis. These findings show that PINK1-parkin-mediated mitophagy defects lead to an accumulation of damaged mitochondria, thus suggesting that interventions that stimulate mitophagy may be potential therapeutic targets for prion diseases.

OMA1 maintains the stemness of glioma stem cells by inducing mitochondrial fission/fusion imbalance

“…3b), indicating that OMA1-depleted GBM cells cannot activate mitophagy during mitochondrial stress. Furthermore, depletion of Pink1 [41] and TBC1D15 [42] reproduced mitochondrial accumulation in si-OMA1 GBM cells, further supporting the role of OMA1 in mitophagy regulation (Supplementary Fig. 3d-e).…”

Monoterpenoid Epoxidiol Ameliorates the Pathological Phenotypes of the Rotenone-Induced Parkinson’s Disease Model by Alleviating Mitochondrial Dysfunction

“…The toxicity shown for rotenone can be induced by apoptosis using various mechanisms, among which the key is its ability to lead to the dissipation of the mitochondrial transmembrane potential. This correlates with the pathological condition in Parkinson’s disease, when, due to a deficiency of PTEN-induced kinase 1 (PINK1), there is a decrease in the basement membrane potential and an impairment of calcium homeostasis [ 61 ], leading to the vulnerability of neurons to the opening of a transitional permeability pore, followed by the death of nerve cells [ 62 ]. When monitoring representative tracks showing the dynamic reaction of the transmembrane potential in response to the sequential addition of subthreshold nontoxic concentrations of rotenone, we detected a step-by-step increase in the fluorescence signal.…”

Mitophagy and Traumatic Brain Injury: Regulatory Mechanisms and Therapeutic Potentials

“…In previous studies, PINK1 deficient cells can also activate mitophagy [51]. Defective mitochondria can also be eliminated in an ubiquitin-independent manner by LC3 adaptors [52].…”